Christopher Leibman

826 total citations
27 papers, 649 citations indexed

About

Christopher Leibman is a scholar working on Economics and Econometrics, Physiology and Psychiatry and Mental health. According to data from OpenAlex, Christopher Leibman has authored 27 papers receiving a total of 649 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Economics and Econometrics, 10 papers in Physiology and 9 papers in Psychiatry and Mental health. Recurrent topics in Christopher Leibman's work include Health Systems, Economic Evaluations, Quality of Life (12 papers), Dementia and Cognitive Impairment Research (9 papers) and Asthma and respiratory diseases (7 papers). Christopher Leibman is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (12 papers), Dementia and Cognitive Impairment Research (9 papers) and Asthma and respiratory diseases (7 papers). Christopher Leibman collaborates with scholars based in United States, United Kingdom and Canada. Christopher Leibman's co-authors include Trent McLaughlin, Michael Grundman, Maki Daniels, Leon J. Thal, Ronald S. Black, Nick C. Fox, M. Pomfret, Connie A. Tompkins, Gordon McLennan and Bruno Vellas and has published in prestigious journals such as Neurology, Journal of Allergy and Clinical Immunology and Journal of the American Geriatrics Society.

In The Last Decade

Christopher Leibman

25 papers receiving 625 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christopher Leibman United States	12	299	256	148	128	84	27	649
Oliver Langford United States	14	168 0.6×	263 1.0×	137 0.9×	66 0.5×	21 0.3×	27	579
Sylvie Pariel France	10	130 0.4×	177 0.7×	26 0.2×	135 1.1×	54 0.6×	23	559
Dawn Farrell Ireland	10	158 0.5×	326 1.3×	123 0.8×	87 0.7×	241 2.9×	17	926
Andrew D. Mosholder United States	15	157 0.5×	192 0.8×	57 0.4×	23 0.2×	69 0.8×	38	743
Jesús López‐Arrieta Spain	9	152 0.5×	121 0.5×	94 0.6×	199 1.6×	37 0.4×	14	648
Patricia Sacco United States	13	168 0.6×	103 0.4×	31 0.2×	45 0.4×	17 0.2×	27	579
Gustavo Jimenez‐Maggiora United States	13	143 0.5×	202 0.8×	72 0.5×	41 0.3×	19 0.2×	23	391
Sally Mannix United States	17	48 0.2×	329 1.3×	134 0.9×	70 0.5×	54 0.6×	33	731
Ingrid S. van Maurik Netherlands	17	253 0.8×	476 1.9×	106 0.7×	139 1.1×	20 0.2×	42	685
Aurel O. Iuga United States	7	74 0.2×	96 0.4×	146 1.0×	102 0.8×	17 0.2×	8	800

Countries citing papers authored by Christopher Leibman

Since Specialization

Citations

This map shows the geographic impact of Christopher Leibman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Leibman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Leibman more than expected).

Fields of papers citing papers by Christopher Leibman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Leibman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Leibman. The network helps show where Christopher Leibman may publish in the future.

Co-authorship network of co-authors of Christopher Leibman

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Leibman. A scholar is included among the top collaborators of Christopher Leibman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Leibman. Christopher Leibman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lacey, Loretto, Joel Bobula, Timothy Niecko, & Christopher Leibman. (2016). Informal Care Time and Cost in a Large Clinical Trial Sample of Patients with Mild to Moderate Alzheimer’s Disease: Determinants and Level of Change Observed. Neurology and Therapy. 6(1). 11–23. 7 indexed citations

Lacey, Loretto, et al.. (2013). Association between illness progression measures and total cost in Alzheimer's disease. The journal of nutrition health & aging. 17(9). 745–750. 13 indexed citations

Lacey, Loretto, et al.. (2011). P3‐404: Relationship between patient dependence on others and clinical measures of cognition, function and behavior in Alzheimer's disease (AD): Results from a longitudinal study. Alzheimer s & Dementia. 7(4S_Part_18). 1 indexed citations

Arrighi, H. Michael, Trent McLaughlin, & Christopher Leibman. (2010). Prevalence and Impact of Dementia-related Functional Limitations in the United States, 2001 to 2005. Alzheimer Disease & Associated Disorders. 24(1). 72–78. 14 indexed citations

Fillit, Howard, et al.. (2010). Novel approaches to incorporating pharmacoeconomic studies into phase III clinical trials for Alzheimer's disease. The journal of nutrition health & aging. 14(8). 640–647. 8 indexed citations

McLaughlin, Trent, Howard Feldman, Howard Fillit, et al.. (2010). Dependence as a unifying construct in defining Alzheimer's disease severity. Alzheimer s & Dementia. 6(6). 482–493. 57 indexed citations

Malone, Daniel C., Trent P. McLaughlin, Peter Wahl, et al.. (2009). Burden of Alzheimer's disease and association with negative health outcomes.. PubMed. 15(8). 481–8. 42 indexed citations

Vellas, Bruno, Ronald S. Black, Leon J. Thal, et al.. (2009). Long-Term Follow-Up of Patients Immunized with AN1792: Reduced Functional Decline in Antibody Responders. Current Alzheimer Research. 6(2). 144–151. 191 indexed citations

Zhu, Carolyn W., Christopher Leibman, R. D. Townsend, et al.. (2009). Bridging from clinical endpoints to estimates of treatment value for external decision makers. The journal of nutrition health & aging. 13(3). 256–259. 10 indexed citations

10.

Hauber, Brett, F. Reed Johnson, Howard Fillit, et al.. (2009). Older Americans' Risk-benefit Preferences for Modifying the Course of Alzheimer Disease. Alzheimer Disease & Associated Disorders. 23(1). 23–32. 25 indexed citations

11.

Murman, Daniel L., Mary E. Charlton, Robin High, Christopher Leibman, & Trent McLaughlin. (2009). P3‐221: Predicting costs of care for unique dependence levels in patients with Alzheimer's disease. Alzheimer s & Dementia. 5(4S_Part_13). 3 indexed citations

12.

Zhu, Carolyn W., Christopher Leibman, Trent McLaughlin, et al.. (2008). Patient Dependence and Longitudinal Changes in Costs of Care in Alzheimer’s Disease. Dementia and Geriatric Cognitive Disorders. 26(5). 416–423. 63 indexed citations

13.

Zhu, Carolyn W., Christopher Leibman, Trent McLaughlin, et al.. (2008). The Effects of Patient Function and Dependence on Costs of Care in Alzheimer's Disease. Journal of the American Geriatrics Society. 56(8). 1497–1503. 57 indexed citations

14.

McLaughlin, Trent, Christopher Leibman, Pankaj Patel, & Carlos A. Camargo. (2007). Risk of recurrent emergency department visits or hospitalizations in children with asthma receiving nebulized budesonide inhalation suspension compared with other asthma medications. Current Medical Research and Opinion. 23(6). 1319–1328. 13 indexed citations

15.

Hauber, Brett, et al.. (2007). PND32 ALZHEIMER'S DISEASE PROGRESSION HEALTHY-YEAR EQUIVALENTS: STATED RISK-BENEFIT TRADE-OFF PREFERENCES. Value in Health. 10(6). A390–A390. 1 indexed citations

16.

O’Connor, Richard D., Bhash Parasuraman, Craig S. Roberts, & Christopher Leibman. (2006). Inhaled corticosteroids vs leukotriene receptor antagonists: health care costs across varying asthma severities. Annals of Allergy Asthma & Immunology. 97(2). 236–243. 7 indexed citations

17.

Schätz, Michael & Christopher Leibman. (2005). Inhaled corticosteroid use and outcomes in pregnancy. Annals of Allergy Asthma & Immunology. 95(3). 234–238. 35 indexed citations

18.

Mahadevia, Parthiv J., Shailen Shah, Christopher Leibman, Leah Kleinman, & L. O'Dowd. (2004). Patient preferences for sensory attributes of intranasal corticosteroids and willingness to adhere to prescribed therapy for allergic rhinitis: a conjoint analysis. Annals of Allergy Asthma & Immunology. 93(4). 345–350. 50 indexed citations

19.

Lee, Todd A., et al.. (2004). Evaluating the efficiency of treatment in the allergic rhinitis market.. PubMed. 10(1 Suppl). S3–8. 6 indexed citations

20.

Leibman, Christopher, Dev S. Pathak, Paul Dorinsky, et al.. (2002). Cost-effectiveness analysis of fluticasone propionate/salmeterol combination versus montelukast in the treatment of adults with asthma. Journal of Allergy and Clinical Immunology. 109(1). S185–S185. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact